Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol. 2011 Oct; 12(11):1004-12.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Agents
Australia
Carcinoma, Non-Small-Cell Lung
Clinical Trials, Phase I as Topic
Female
Gene Rearrangement
Humans
Kaplan-Meier Estimate
Lung Neoplasms
Male
Middle Aged
Multicenter Studies as Topic
Patient Selection
Proportional Hazards Models
Protein Kinase Inhibitors
Pyrazoles
Pyridines
Receptor Protein-Tyrosine Kinases
Retrospective Studies
Risk Assessment
Risk Factors
Survival Rate
Time Factors
Treatment Outcome
United States

authors with profiles

Ravi Salgia